Circulating tumour DNA to monitor treatment response and resistance in chronic lymphocytic leukemia

被引：0
|
作者：
Sinha, Devbarna [1 ]
Ftouni, Sarah [1 ]
Hunter, Tane [1 ]
Yeh, Paul [1 ]
Wallach, Elise [1 ]
Wong, Stephen [1 ]
Petrone, Pasquale [1 ]
Seymour, John F. [1 ]
Dawson, Mark A. [1 ]
Tam, Constantine [1 ]
Dawson, Sarah-Jane [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
来源：
LEUKEMIA & LYMPHOMA | 2015年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
99
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [21] Inhibition of DNA repair vis-a-vis resistance in chronic lymphocytic leukemia
    Amrein, L.
    Loignon, M.
    Aloyz, R.
    Panasci, L.
    EJC SUPPLEMENTS, 2006, 4 (12): : 152 - 152
  • [22] Chlorambucil drug resistance in chronic lymphocytic leukemia: The emerging role of DNA repair
    Panasci, L
    Paiement, JP
    Christodouplopoulos, G
    Belenkov, A
    Malapetsa, A
    Aloyz, R
    CLINICAL CANCER RESEARCH, 2001, 7 (03) : 454 - 461
  • [23] NATURE OF CIRCULATING LYMPHOCYTE IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    DAVIS, S
    SCHULTZ, EF
    RUBIN, AD
    CLINICAL RESEARCH, 1975, 23 (03): : A337 - A337
  • [24] FURTHER CHARACTERIZATION OF CIRCULATING CELL IN CHRONIC LYMPHOCYTIC LEUKEMIA
    SCHULTZ, EF
    DAVIS, S
    RUBIN, AD
    BLOOD, 1976, 48 (02) : 223 - 234
  • [25] Circulating endothelial cells in patients with chronic lymphocytic leukemia
    Ronald S. Go
    Dean A. Jobe
    Krista E. Asp
    Steven M. Callister
    Michelle A. Mathiason
    Lori A. Meyer
    Wayne A. Bottner
    Craig E. Cole
    John P. Farnen
    Kathleen A. Frisby
    Annals of Hematology, 2008, 87 : 369 - 373
  • [26] Circulating endothelial cells in patients with chronic lymphocytic leukemia
    Go, Ronald S.
    Jobe, Dean A.
    Asp, Krista E.
    Callister, Steven M.
    Mathiason, Michelle A.
    Meyer, Lori A.
    Bottner, Wayne A.
    Cole, Craig E.
    Farnen, John P.
    Frisby, Kathleen A.
    ANNALS OF HEMATOLOGY, 2008, 87 (05) : 369 - 373
  • [27] Exploring the potential of circulating tumour DNA to monitor treatment response in salivary duct carcinoma patients of the CABO-ASAP trial
    Weijers, Jetty A. M.
    de Bitter, Tessa J. J.
    Verhaegh, Gerald W.
    van Boxtel, Wim
    Uijen, Maike J. M.
    van Engen-van Grunsven, Adriana C. H.
    Driessen, Chantal M. L.
    Schalken, Jack A.
    Ligtenberg, Marjolijn J. L.
    van Herpen, Carla M. L.
    ORAL ONCOLOGY, 2023, 147
  • [28] Apparent feline leukemia virus-induced chronic lymphocytic leukemia and response to treatment
    Kyle, Kristy N.
    Wright, Zachary
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2010, 12 (04) : 341 - 344
  • [29] ANALYSIS OF TREATMENT RESPONSE IN CHRONIC LYMPHOCYTIC-LEUKEMIA - NEW APPROACHES
    WORMSLEY, SB
    RAI, KR
    GALE, RP
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1988, 30 (5-6): : 413 - 417
  • [30] Circulating tumour DNA: A new biomarker to monitor resistance in NSCLC patients treated with EGFR-TKIs
    Diao, Zhenli
    Han, Yanxi
    Zhang, Rui
    Li, Jinming
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2020, 1873 (02):
12345